Cargando…
Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
Bioimpedance spectroscopy (BIS) is routinely used in peritoneal dialysis patients and might aid fluid status assessment in patients with liver cirrhosis, but the effect of ascites volume removal on BIS-readings is unknown. Here we determined changes in BIS-derived parameters and clinical signs of fl...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028989/ https://www.ncbi.nlm.nih.gov/pubmed/32071351 http://dx.doi.org/10.1038/s41598-020-59817-3 |
_version_ | 1783499077567119360 |
---|---|
author | Schwaiger, Elisabeth Simon, Amrei Wabel, Peter Schairer, Benjamin Berner, Carolin Signorini, Lorenzo Ernstbrunner, Matthäus Evstatiev, Rayko Schwabl, Philipp Hinterholzer, Georg Frommlet, Florian Vychytil, Andreas Müller, Christian J. Hecking, Manfred |
author_facet | Schwaiger, Elisabeth Simon, Amrei Wabel, Peter Schairer, Benjamin Berner, Carolin Signorini, Lorenzo Ernstbrunner, Matthäus Evstatiev, Rayko Schwabl, Philipp Hinterholzer, Georg Frommlet, Florian Vychytil, Andreas Müller, Christian J. Hecking, Manfred |
author_sort | Schwaiger, Elisabeth |
collection | PubMed |
description | Bioimpedance spectroscopy (BIS) is routinely used in peritoneal dialysis patients and might aid fluid status assessment in patients with liver cirrhosis, but the effect of ascites volume removal on BIS-readings is unknown. Here we determined changes in BIS-derived parameters and clinical signs of fluid overload from before to after abdominal paracentesis. Per our pre-specified sample size calculation, we studied 31 cirrhotic patients, analyzing demographics, labs and clinical parameters along with BIS results. Mean volume of the abdominal paracentesis was 7.8 ± 2.6 L. From pre-to post-paracentesis, extracellular volume (ECV) decreased (20.2 ± 5.2 L to 19.0 ± 4.8 L), total body volume decreased (39.8 ± 9.8 L to 37.8 ± 8.5 L) and adipose tissue mass decreased (38.4 ± 16.0 kg to 29.9 ± 12.9 kg; all p < 0.002). Correlation of BIS-derived parameters from pre to post-paracentesis ranged from R² = 0.26 for body cell mass to R² = 0.99 for ECV. Edema did not correlate with BIS-derived fluid overload (FO ≥ 15% ECV), which occurred in 16 patients (51.6%). In conclusion, BIS-derived information on fluid status did not coincide with clinical judgement. The changes in adipose tissue mass support the BIS-model assumption that fluid in the peritoneal cavity is not detectable, suggesting that ascites (or peritoneal dialysis fluid) mass should be subtracted from adipose tissue if BIS is used in patients with a full peritoneal cavity. |
format | Online Article Text |
id | pubmed-7028989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70289892020-02-26 Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis Schwaiger, Elisabeth Simon, Amrei Wabel, Peter Schairer, Benjamin Berner, Carolin Signorini, Lorenzo Ernstbrunner, Matthäus Evstatiev, Rayko Schwabl, Philipp Hinterholzer, Georg Frommlet, Florian Vychytil, Andreas Müller, Christian J. Hecking, Manfred Sci Rep Article Bioimpedance spectroscopy (BIS) is routinely used in peritoneal dialysis patients and might aid fluid status assessment in patients with liver cirrhosis, but the effect of ascites volume removal on BIS-readings is unknown. Here we determined changes in BIS-derived parameters and clinical signs of fluid overload from before to after abdominal paracentesis. Per our pre-specified sample size calculation, we studied 31 cirrhotic patients, analyzing demographics, labs and clinical parameters along with BIS results. Mean volume of the abdominal paracentesis was 7.8 ± 2.6 L. From pre-to post-paracentesis, extracellular volume (ECV) decreased (20.2 ± 5.2 L to 19.0 ± 4.8 L), total body volume decreased (39.8 ± 9.8 L to 37.8 ± 8.5 L) and adipose tissue mass decreased (38.4 ± 16.0 kg to 29.9 ± 12.9 kg; all p < 0.002). Correlation of BIS-derived parameters from pre to post-paracentesis ranged from R² = 0.26 for body cell mass to R² = 0.99 for ECV. Edema did not correlate with BIS-derived fluid overload (FO ≥ 15% ECV), which occurred in 16 patients (51.6%). In conclusion, BIS-derived information on fluid status did not coincide with clinical judgement. The changes in adipose tissue mass support the BIS-model assumption that fluid in the peritoneal cavity is not detectable, suggesting that ascites (or peritoneal dialysis fluid) mass should be subtracted from adipose tissue if BIS is used in patients with a full peritoneal cavity. Nature Publishing Group UK 2020-02-18 /pmc/articles/PMC7028989/ /pubmed/32071351 http://dx.doi.org/10.1038/s41598-020-59817-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Schwaiger, Elisabeth Simon, Amrei Wabel, Peter Schairer, Benjamin Berner, Carolin Signorini, Lorenzo Ernstbrunner, Matthäus Evstatiev, Rayko Schwabl, Philipp Hinterholzer, Georg Frommlet, Florian Vychytil, Andreas Müller, Christian J. Hecking, Manfred Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis |
title | Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis |
title_full | Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis |
title_fullStr | Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis |
title_full_unstemmed | Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis |
title_short | Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis |
title_sort | bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: implications for peritoneal dialysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028989/ https://www.ncbi.nlm.nih.gov/pubmed/32071351 http://dx.doi.org/10.1038/s41598-020-59817-3 |
work_keys_str_mv | AT schwaigerelisabeth bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT simonamrei bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT wabelpeter bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT schairerbenjamin bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT bernercarolin bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT signorinilorenzo bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT ernstbrunnermatthaus bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT evstatievrayko bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT schwablphilipp bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT hinterholzergeorg bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT frommletflorian bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT vychytilandreas bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT mullerchristianj bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis AT heckingmanfred bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis |